Variant report

Variant	nsv540974
Chromosome Location	chr11:26532655-26675303
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1211)
CpG islands
(count:427)
Chromatin interactive
region (count:11)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1211 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr11:26644736-26644808	K562	blood:	n/a	n/a
2	ATF1	chr11:26671444-26671614	K562	blood:	n/a	n/a
3	ATF2	chr11:26654070-26654702	GM12878	blood:	n/a	n/a
4	ATF2	chr11:26654088-26654778	GM12878	blood:	n/a	n/a
5	ATF2	chr11:26629236-26629961	GM12878	blood:	n/a	n/a
6	ATF2	chr11:26544464-26545008	H1-hESC	embryonic stem cell:	n/a	n/a
7	ATF2	chr11:26629324-26629821	GM12878	blood:	n/a	n/a
8	BATF	chr11:26644564-26644856	GM12878	blood:	n/a	chr11:26644777-26644787
9	BATF	chr11:26629279-26629906	GM12878	blood:	n/a	n/a
10	BATF	chr11:26644625-26644850	GM12878	blood:	n/a	chr11:26644777-26644787
11	BATF	chr11:26654375-26654648	GM12878	blood:	n/a	n/a
12	BCL11A	chr11:26629435-26629822	GM12878	blood:	n/a	n/a
13	BCL11A	chr11:26654235-26654678	GM12878	blood:	n/a	n/a
14	BCL11A	chr11:26629487-26629695	GM12878	blood:	n/a	n/a
15	BHLHE40	chr11:26673393-26673826	GM12878	blood:	n/a	n/a
16	BHLHE40	chr11:26637164-26637178	GM12878	blood:	n/a	n/a
17	BHLHE40	chr11:26654159-26654713	GM12878	blood:	n/a	n/a
18	BHLHE40	chr11:26671480-26671680	K562	blood:	n/a	n/a
19	BHLHE40	chr11:26629582-26630703	GM12878	blood:	n/a	n/a
20	BHLHE40	chr11:26573138-26573273	GM12878	blood:	n/a	n/a
21	BHLHE40	chr11:26671338-26671661	GM12878	blood:	n/a	n/a
22	BHLHE40	chr11:26593452-26593724	GM12878	blood:	n/a	n/a
23	BRCA1	chr11:26544501-26545118	H1-hESC	embryonic stem cell:	n/a	n/a
24	BRCA1	chr11:26629866-26629936	GM12878	blood:	n/a	n/a
25	BRCA1	chr11:26671378-26671648	Hela-S3	cervix:	n/a	n/a
26	CEBPB	chr11:26597168-26597409	A549	lung:	n/a	chr11:26597230-26597241
27	CEBPB	chr11:26605018-26605520	ECC-1	luminal epithelium:	n/a	chr11:26605215-26605226 chr11:26605270-26605281
28	CEBPB	chr11:26605110-26605438	HepG2	liver:	n/a	chr11:26605215-26605226 chr11:26605270-26605281
29	CEBPB	chr11:26644803-26645198	A549	lung:	n/a	chr11:26645011-26645024 chr11:26645012-26645023
30	CEBPB	chr11:26597186-26597322	Hela-S3	cervix:	n/a	chr11:26597230-26597241
31	CEBPB	chr11:26642654-26643019	Hela-S3	cervix:	n/a	n/a
32	CEBPB	chr11:26644515-26645327	A549	lung:	n/a	chr11:26645011-26645024 chr11:26645012-26645023
33	CEBPB	chr11:26636744-26637059	HepG2	liver:	n/a	n/a
34	CEBPB	chr11:26581580-26581780	H1-hESC	embryonic stem cell:	n/a	chr11:26581747-26581758
35	CEBPB	chr11:26605130-26605428	IMR90	lung:	n/a	chr11:26605215-26605226 chr11:26605270-26605281
36	CEBPB	chr11:26619481-26619823	HepG2	liver:	n/a	chr11:26619645-26619656 chr11:26619643-26619654
37	CEBPB	chr11:26605103-26605470	Hela-S3	cervix:	n/a	chr11:26605215-26605226 chr11:26605270-26605281
38	CEBPB	chr11:26621046-26621332	HepG2	liver:	n/a	chr11:26621231-26621242
39	CEBPB	chr11:26595511-26595872	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr11:26611345-26611681	HepG2	liver:	n/a	n/a
41	CEBPB	chr11:26619563-26619772	A549	lung:	n/a	chr11:26619645-26619656 chr11:26619643-26619654
42	CEBPB	chr11:26636897-26636936	H1-hESC	embryonic stem cell:	n/a	n/a
43	CEBPB	chr11:26621018-26621383	A549	lung:	n/a	chr11:26621231-26621242
44	CEBPB	chr11:26581619-26581894	IMR90	lung:	n/a	chr11:26581747-26581758
45	CEBPB	chr11:26642624-26642961	A549	lung:	n/a	n/a
46	CEBPB	chr11:26555262-26555494	HepG2	liver:	n/a	n/a
47	CEBPB	chr11:26644864-26645084	HepG2	liver:	n/a	chr11:26645011-26645024 chr11:26645012-26645023
48	CEBPB	chr11:26619512-26619802	IMR90	lung:	n/a	chr11:26619645-26619656 chr11:26619643-26619654
49	CEBPB	chr11:26581593-26581864	A549	lung:	n/a	chr11:26581747-26581758
50	CEBPB	chr11:26597092-26597408	K562	blood:	n/a	chr11:26597230-26597241

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:26594620-26594670	HCF	heart:	n/a
2	chr11:26581996-26582046	HPAEpiC	pulmonary alveolar:	n/a
3	chr11:26593556-26593606	SK-N-SH	brain:	n/a
4	chr11:26594620-26594670	H1-hESC	embryonic stem cell:	embryo
5	chr11:26581996-26582046	GM19239	blood:	n/a
6	chr11:26594620-26594670	AG10803	skin:	n/a
7	chr11:26594782-26594832	HEEpiC	esophagus:	n/a
8	chr11:26594782-26594832	ECC-1	luminal epithelium:	n/a
9	chr11:26594620-26594670	MCF-7	breast:	n/a
10	chr11:26544953-26545003	AG04450	lung:	fetal
11	chr11:26593658-26593708	AoSMC	blood vessel:	n/a
12	chr11:26544953-26545003	CMK	blood:	n/a
13	chr11:26593881-26593931	SK-N-SH_RA	brain:	n/a
14	chr11:26593881-26593931	HL-60	blood:	n/a
15	chr11:26581996-26582046	SAEC	small airway:	n/a
16	chr11:26593658-26593708	HNPCEpiC	eye:	n/a
17	chr11:26594620-26594670	HUVEC	blood vessel:	n/a
18	chr11:26581996-26582046	PANC-1	pancreas:	n/a
19	chr11:26593658-26593708	MCF10A-Er-Src	breast:	n/a
20	chr11:26593658-26593708	PFSK-1	brain:	n/a
21	chr11:26593881-26593931	ECC-1	luminal epithelium:	n/a
22	chr11:26593658-26593708	GM12892	blood:	n/a
23	chr11:26544953-26545003	T-47D	breast:	n/a
24	chr11:26594620-26594670	GM12892	blood:	n/a
25	chr11:26544953-26545003	Hela-S3	cervix:	n/a
26	chr11:26581996-26582046	SKMC	muscle:	n/a
27	chr11:26544953-26545003	HEK293	kidney:	embryo
28	chr11:26593658-26593708	HCF	heart:	n/a
29	chr11:26594620-26594670	HRE	kidney:	n/a
30	chr11:26593556-26593606	PFSK-1	brain:	n/a
31	chr11:26594620-26594670	MCF10A-Er-Src	breast:	n/a
32	chr11:26593881-26593931	NHBE	bronchial:	n/a
33	chr11:26594620-26594670	HL-60	blood:	n/a
34	chr11:26593881-26593931	PANC-1	pancreas:	n/a
35	chr11:26594782-26594832	SK-N-SH_RA	brain:	n/a
36	chr11:26594782-26594832	PrEC	prostate:	n/a
37	chr11:26544953-26545003	NT2-D1	testis:	n/a
38	chr11:26544953-26545003	GM12891	blood:	n/a
39	chr11:26593881-26593931	HAEpiC	amniotic membrane:	n/a
40	chr11:26594782-26594832	HRPEpiC	eye:	n/a
41	chr11:26581996-26582046	HRPEpiC	eye:	n/a
42	chr11:26593881-26593931	HCF	heart:	n/a
43	chr11:26544953-26545003	Jurkat	blood:	n/a
44	chr11:26593556-26593606	HepG2	liver:	n/a
45	chr11:26594620-26594670	T-47D	breast:	n/a
46	chr11:26593881-26593931	HEK293	kidney:	embryo
47	chr11:26581996-26582046	ProgFib	skin:	n/a
48	chr11:26544953-26545003	AoSMC	blood vessel:	n/a
49	chr11:26593881-26593931	HRE	kidney:	n/a
50	chr11:26593658-26593708	AG04450	lung:	fetal

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:26629270..26631902-chr11:26633613..26635854,2	K562	blood:
2	chr11:26586123..26588285-chr11:26619056..26621228,2	K562	blood:
3	chr11:26318438..26319350-chr11:26670793..26671982,7	MCF-7	breast:
4	chr11:26669136..26671365-chr14:104584975..104586845,2	MCF-7	breast:
5	chr11:26318636..26319225-chr11:26543911..26544770,2	MCF-7	breast:
6	chr11:26544159..26545613-chr11:26671003..26672359,7	MCF-7	breast:
7	chr11:26594478..26596618-chr11:26598306..26601067,2	MCF-7	breast:
8	chr11:26544159..26545613-chr11:26671003..26672359,7	MCF-7	breast:
9	chr11:26586123..26588285-chr11:26619056..26621228,2	K562	blood:
10	chr11:26594478..26596618-chr11:26598306..26601067,2	MCF-7	breast:
11	chr11:26629270..26631902-chr11:26633613..26635854,2	K562	blood:

No data

Variant related genes	Relation type
MUC15	TF binding region
ANO3	TF binding region
MUC15	CpG island
ANO3	CpG island

Extended variants
information (count: 5752 )
Associated
traits (count: 57 )

Variant overlapped rSNPs/rCNVs (count:5752 , 50 per page) page: 1 2 3 4 5 6 7 ... 116

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs117402738	chr11:26532672-26532673	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs534922337	chr11:26532688-26532689	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs375136643	chr11:26532771-26532772	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs561455076	chr11:26532786-26532787	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs117823677	chr11:26532818-26532819	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs137973183	chr11:26532841-26532842	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs56070600	chr11:26532851-26532852	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs371536397	chr11:26532853-26532854	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs113958511	chr11:26532902-26532903	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs142506829	chr11:26532975-26532976	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs12290955	chr11:26532976-26532977	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs12284101	chr11:26533032-26533033	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs567534313	chr11:26533039-26533040	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs57660147	chr11:26533043-26533044	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs149487243	chr11:26533112-26533113	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs534638499	chr11:26533140-26533141	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs143856782	chr11:26533167-26533168	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs117808631	chr11:26533191-26533192	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs190083563	chr11:26533215-26533216	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs572487894	chr11:26533252-26533253	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs113379291	chr11:26533326-26533327	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs553663285	chr11:26533337-26533338	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs565706666	chr11:26533378-26533379	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs117554013	chr11:26533395-26533396	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs554749132	chr11:26533407-26533408	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs77397516	chr11:26533453-26533454	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs77545197	chr11:26533457-26533458	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs377351337	chr11:26533465-26533466	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs543980136	chr11:26533473-26533474	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs140298168	chr11:26533534-26533535	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs180978419	chr11:26533542-26533543	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs117257643	chr11:26533547-26533548	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs17243357	chr11:26533558-26533559	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs553202118	chr11:26533573-26533574	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs542451538	chr11:26533595-26533596	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs185006148	chr11:26533614-26533615	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs531392803	chr11:26533627-26533628	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs116900912	chr11:26533644-26533645	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs373891453	chr11:26533650-26533651	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs190931514	chr11:26533680-26533681	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs376469078	chr11:26533688-26533689	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs532000783	chr11:26533702-26533703	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs144246741	chr11:26533727-26533728	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs565998676	chr11:26533729-26533730	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs114375196	chr11:26533737-26533738	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs183956344	chr11:26533776-26533777	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs569760543	chr11:26533781-26533782	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs187225364	chr11:26533789-26533790	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs367808001	chr11:26533875-26533876	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs147535950	chr11:26533889-26533890	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:57)

Disease	PMID	Source
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	16783165	CNVD
small cell lung cancer	20016488	CNVD
Congenital diaphragmatic hernia	21525063	CNVD
Renal cell carcinoma	18194544	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
Chordoma	18071362	CNVD
Autism	22102821	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	21364760	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Neuroticism	17667963	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Ependymoma	20639864	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD

Chromatin state (count:302 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:26506400-26564600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
2	chr11:26531200-26533800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
3	chr11:26532400-26534000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
4	chr11:26532600-26533600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
5	chr11:26533800-26534000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
6	chr11:26533800-26540800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr11:26540800-26542000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr11:26540800-26543200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
9	chr11:26541000-26542000	Enhancers	Adipose Nuclei	Adipose
10	chr11:26544400-26545200	Active TSS	HUES64 Cell Line	embryonic stem cell
11	chr11:26544400-26545200	Active TSS	iPS-18 Cell Line	embryonic stem cell
12	chr11:26544400-26545400	Active TSS	HUES6 Cell Line	embryonic stem cell
13	chr11:26544400-26545600	Active TSS	HUES48 Cell Line	embryonic stem cell
14	chr11:26544600-26545000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr11:26544600-26545200	Active TSS	ES-I3 Cell Line	embryonic stem cell
16	chr11:26544600-26545200	Active TSS	ES-WA7 Cell Line	embryonic stem cell
17	chr11:26544600-26545200	Active TSS	H9 Cell Line	embryonic stem cell
18	chr11:26544600-26545400	Active TSS	iPS-15b Cell Line	embryonic stem cell
19	chr11:26544600-26545400	Active TSS	iPS-20b Cell Line	embryonic stem cell
20	chr11:26544800-26545200	Active TSS	H1 Cell Line	embryonic stem cell
21	chr11:26544800-26545200	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
22	chr11:26545200-26545400	Enhancers	HUES64 Cell Line	embryonic stem cell
23	chr11:26545200-26545400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
24	chr11:26545400-26545600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
25	chr11:26545400-26545600	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
26	chr11:26545400-26545800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
27	chr11:26545400-26546000	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
28	chr11:26545400-26546400	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
29	chr11:26545600-26545800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
30	chr11:26545600-26545800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
31	chr11:26545600-26545800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
32	chr11:26545600-26546200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
33	chr11:26546400-26546600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
34	chr11:26558800-26559400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr11:26564600-26565000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr11:26565000-26599200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
37	chr11:26570200-26570600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
38	chr11:26570800-26571400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr11:26571400-26572400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr11:26572600-26572800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr11:26578000-26578600	Enhancers	Stomach Mucosa	stomach
42	chr11:26578200-26578600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
43	chr11:26579200-26580600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
44	chr11:26579600-26580000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
45	chr11:26579800-26592600	Weak transcription	Placenta	Placenta
46	chr11:26580000-26580200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
47	chr11:26590400-26590800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
48	chr11:26590800-26591000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
49	chr11:26590800-26591000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr11:26590800-26591600	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links